About Socrus Bio Sciences Limited
Data last updated: 23 February 2026
Socrus Bio Sciences Limited is a public limited company based in Mumbai, Maharashtra, India. It specialises in software development and support services, a part of the broader technology and IT services sector. Incorporated on 25 October 1989, the company has been in operation for over 37 years.
Registered with ROC Mumbai under CIN L99999MH1989PLC054030.
Capital: an authorised share capital of ₹32.01 Cr and a paid-up capital of ₹32 Cr. Formerly known as Shreeji Analytical Lab Pvt Ltd and Tanu Healthcare Limited. It is led by directors including Madhvi Agnihotri and Sunil Kumar Jain.
Last AGM: 29 September 2010. Financial statements filed for year ended 31 March 2010. Office: 30 16 – A Pmgp Colony Mahakali Cave Road Andheri (E), Mumbai, Maharashtra, India – 400093.
The current compliance status is marked as active non-compliant by the Registrar of Companies. For more details, the company can be reached via its website socrus.com.
-
Email**************
-
Telephone**************
-
Website**************
-
Social Media**************
-
Registered Address30 16 – A Pmgp Colony Mahakali Cave Road Andheri (E), Mumbai, Maharashtra, India – 400093
-
IndustryInformation Technology, Software Development & Support Services
- Historical Financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Litigation, compliance and MCA filings
- PDF report delivered after checkout
Name History of Socrus Bio Sciences Limited
Socrus Bio Sciences Limited has undergone 2 name changes throughout its history. The company was previously known as Shreeji Analytical Lab Pvt Ltd, and Tanu Healthcare Limited. The current legal name is Socrus Bio Sciences Limited, reflecting the company's evolution and rebranding over time.
| Company Name | Status |
|---|---|
| Socrus Bio Sciences Limited | Current |
| Shreeji Analytical Lab Pvt Ltd | Previous |
| Tanu Healthcare Limited | Previous |
CIN History of Socrus Bio Sciences Limited
Socrus Bio Sciences Limited has one previous CIN (Corporate Identification Number): L99999MH1989PLC054030. The current CIN is U99999MH1989PLC054030, which is the unique identifier assigned by the Registrar of Companies.
| CIN | Status |
|---|---|
| U99999MH1989PLC054030 | Current |
| L99999MH1989PLC054030 | Previous |
Board of Directors of Socrus Bio Sciences Limited
Socrus Bio Sciences Limited is currently managed by 5 directors, with 8 former directors having served the organization. The current Directors play a crucial role in shaping the company's strategic direction and governance.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
|
Madhvi Agnihotri
Also directs:
Socrus Pharmaceuticals Limited
|
Director | 18 Dec 2007 | 18 Years 6 Months | Current |
| Sunil Kumar Jain | Additional Director | 07 Jul 2009 | 17 Years 0 Months | Current |
| Manish Jain | Additional Director | 07 Jul 2009 | 17 Years 0 Months | Current |
| Rajeev Agnihotri | Managing Director | 26 Nov 2007 | 18 Years 7 Months | Current |
|
Sanjay Kumar Upadhyay
Also directs:
Socrus Pharmaceuticals Limited
|
Additional Director | 07 Jul 2009 | 17 Years 0 Months | Current |
Financials of Socrus Bio Sciences Limited FY 2010 filings available
| Metrics | ***** | ***** | ***** | ***** | ***** |
|---|---|---|---|---|---|
| Revenue | |||||
| Revenue from Operations | ***** | ***** | ***** | ***** | ***** |
| Revenue Growth % | ***** | ***** | ***** | ***** | ***** |
| Other Income | ***** | ***** | ***** | ***** | ***** |
| Total Revenue | ***** | ***** | ***** | ***** | ***** |
| Expenses | |||||
| Total Expenses | ***** | ***** | ***** | ***** | ***** |
| Raw Material Cost | ***** | ***** | ***** | ***** | ***** |
| Change in Inventory FG | ***** | ***** | ***** | ***** | ***** |
| Change in Inventory WIP | ***** | ***** | ***** | ***** | ***** |
| Purchase of Traded Goods | ***** | ***** | ***** | ***** | ***** |
| Employee Cost | ***** | ***** | ***** | ***** | ***** |
| Managerial Remuneration | ***** | ***** | ***** | ***** | ***** |
| Audit Fees | ***** | ***** | ***** | ***** | ***** |
| Insurance | ***** | ***** | ***** | ***** | ***** |
| Power & Fuel | ***** | ***** | ***** | ***** | ***** |
| Interest | ***** | ***** | ***** | ***** | ***** |
| Depreciation | ***** | ***** | ***** | ***** | ***** |
| Other Expenses | ***** | ***** | ***** | ***** | ***** |
| Profitability | |||||
| EBITDA (Operating Profit) | ***** | ***** | ***** | ***** | ***** |
| Operating Margin % | ***** | ***** | ***** | ***** | ***** |
| Exceptional Items | ***** | ***** | ***** | ***** | ***** |
| Extraordinary Items | ***** | ***** | ***** | ***** | ***** |
| Profit Before Exceptional & Extraordinary Items | ***** | ***** | ***** | ***** | ***** |
| Profit Before Tax | ***** | ***** | ***** | ***** | ***** |
| Tax & Net Profit | |||||
| Tax Expense | ***** | ***** | ***** | ***** | ***** |
| Current Tax | ***** | ***** | ***** | ***** | ***** |
| Deferred Tax | ***** | ***** | ***** | ***** | ***** |
| Profit from Discontinued Operations | ***** | ***** | ***** | ***** | ***** |
| Tax on Discontinued Operations | ***** | ***** | ***** | ***** | ***** |
| Profit | ***** | ***** | ***** | ***** | ***** |
| Net Margin % | ***** | ***** | ***** | ***** | ***** |
| Metrics | ***** | ***** | ***** | ***** | ***** |
|---|---|---|---|---|---|
| Shareholders' Funds | |||||
| Total Shareholders' Funds | ***** | ***** | ***** | ***** | ***** |
| Equity Capital | ***** | ***** | ***** | ***** | ***** |
| Reserves & Surplus | ***** | ***** | ***** | ***** | ***** |
| Money Against Warrants | ***** | ***** | ***** | ***** | ***** |
| Other Equity | ***** | ***** | ***** | ***** | ***** |
| Non-Current Liabilities | |||||
| Total Non-Current Liabilities | ***** | ***** | ***** | ***** | ***** |
| Long-Term Borrowings | ***** | ***** | ***** | ***** | ***** |
| Deferred Tax Liabilities | ***** | ***** | ***** | ***** | ***** |
| Other Non-Current Liabilities | ***** | ***** | ***** | ***** | ***** |
| Long-Term Provisions | ***** | ***** | ***** | ***** | ***** |
| Current Liabilities | |||||
| Total Current Liabilities | ***** | ***** | ***** | ***** | ***** |
| Short-Term Borrowings | ***** | ***** | ***** | ***** | ***** |
| Trade Payables | ***** | ***** | ***** | ***** | ***** |
| Other Current Liabilities | ***** | ***** | ***** | ***** | ***** |
| Short-Term Provisions | ***** | ***** | ***** | ***** | ***** |
| Total Equity & Liabilities | ***** | ***** | ***** | ***** | ***** |
| Non-Current Assets | |||||
| Non-Current Assets | ***** | ***** | ***** | ***** | ***** |
| Tangible Assets | ***** | ***** | ***** | ***** | ***** |
| Intangible Assets | ***** | ***** | ***** | ***** | ***** |
| Capital WIP | ***** | ***** | ***** | ***** | ***** |
| Intangibles Under Dev | ***** | ***** | ***** | ***** | ***** |
| Investments | ***** | ***** | ***** | ***** | ***** |
| Deferred Tax Assets | ***** | ***** | ***** | ***** | ***** |
| LT Loans & Advances | ***** | ***** | ***** | ***** | ***** |
| Other Non-Current Assets | ***** | ***** | ***** | ***** | ***** |
| Current Assets | |||||
| Current Assets | ***** | ***** | ***** | ***** | ***** |
| Current Investments | ***** | ***** | ***** | ***** | ***** |
| Inventories | ***** | ***** | ***** | ***** | ***** |
| Trade Receivables | ***** | ***** | ***** | ***** | ***** |
| Cash & Bank Balance | ***** | ***** | ***** | ***** | ***** |
| ST Loans & Advances | ***** | ***** | ***** | ***** | ***** |
| Other Current Assets | ***** | ***** | ***** | ***** | ***** |
| Total Assets | ***** | ***** | ***** | ***** | ***** |
| Metrics | ***** | ***** | ***** | ***** | ***** |
|---|---|---|---|---|---|
| Cash from Operating Activities (CFO) | |||||
| Profit Before Tax | ***** | ***** | ***** | ***** | ***** |
| Non-Cash Adjustments | ***** | ***** | ***** | ***** | ***** |
| + Interest Expense | ***** | ***** | ***** | ***** | ***** |
| + Depreciation | ***** | ***** | ***** | ***** | ***** |
| +/- Unrealized Forex | ***** | ***** | ***** | ***** | ***** |
| - Dividend Income | ***** | ***** | ***** | ***** | ***** |
| - Interest Income | ***** | ***** | ***** | ***** | ***** |
| +/- Other Non-Cash Items | ***** | ***** | ***** | ***** | ***** |
| Changes in Working Capital | ***** | ***** | ***** | ***** | ***** |
| +/- Inventory | ***** | ***** | ***** | ***** | ***** |
| +/- Debtors | ***** | ***** | ***** | ***** | ***** |
| +/- Creditors | ***** | ***** | ***** | ***** | ***** |
| Reconciliation Adjustments | ***** | ***** | ***** | ***** | ***** |
| Cash Generated from Operations | ***** | ***** | ***** | ***** | ***** |
| Income Taxes Paid | ***** | ***** | ***** | ***** | ***** |
| Net CFO (Cash from Operations) | ***** | ***** | ***** | ***** | ***** |
| Cash from Investing Activities (CFI) | |||||
| Acquisitions & Disposals | ***** | ***** | ***** | ***** | ***** |
| Disposal of Subsidiaries | ***** | ***** | ***** | ***** | ***** |
| Acquisition of Subsidiaries | ***** | ***** | ***** | ***** | ***** |
| Capex | ***** | ***** | ***** | ***** | ***** |
| Purchase of Fixed Assets | ***** | ***** | ***** | ***** | ***** |
| Sale of Fixed Assets | ***** | ***** | ***** | ***** | ***** |
| Other Investing Cash Flows | ***** | ***** | ***** | ***** | ***** |
| Net CFI (Cash from Investing) | ***** | ***** | ***** | ***** | ***** |
| Cash from Financing Activities (CFF) | |||||
| Equity Issuance | ***** | ***** | ***** | ***** | ***** |
| Debt Raised | ***** | ***** | ***** | ***** | ***** |
| Debt Repaid | ***** | ***** | ***** | ***** | ***** |
| Dividends Paid | ***** | ***** | ***** | ***** | ***** |
| Interest Paid | ***** | ***** | ***** | ***** | ***** |
| Net CFF (Cash from Financing) | ***** | ***** | ***** | ***** | ***** |
| Net Cash Position | |||||
| Net Change in Cash (Pre-Forex) | ***** | ***** | ***** | ***** | ***** |
| Closing Cash & Equivalents | ***** | ***** | ***** | ***** | ***** |
| Metrics | ***** | ***** | ***** | ***** | ***** |
|---|---|---|---|---|---|
| Liquidity | |||||
| Current Ratio | ***** | ***** | ***** | ***** | ***** |
| Quick Ratio | ***** | ***** | ***** | ***** | ***** |
| Cash Ratio | ***** | ***** | ***** | ***** | ***** |
| Efficiency | |||||
| Inventory Days | ***** | ***** | ***** | ***** | ***** |
| Debtor Days | ***** | ***** | ***** | ***** | ***** |
| Creditor Days | ***** | ***** | ***** | ***** | ***** |
| Cash Conversion Cycle | ***** | ***** | ***** | ***** | ***** |
| Asset Turnover | ***** | ***** | ***** | ***** | ***** |
| Profitability | |||||
| Net Profit Margin % | ***** | ***** | ***** | ***** | ***** |
| Operating Margin % | ***** | ***** | ***** | ***** | ***** |
| ROE % | ***** | ***** | ***** | ***** | ***** |
| ROCE % | ***** | ***** | ***** | ***** | ***** |
| Net Worth Margin % | ***** | ***** | ***** | ***** | ***** |
| Growth | |||||
| Revenue Growth % | ***** | ***** | ***** | ***** | ***** |
| Leverage | |||||
| Equity Multiplier | ***** | ***** | ***** | ***** | ***** |
| Debt / EBITDA | ***** | ***** | ***** | ***** | ***** |
| Solvency | |||||
| D/E Ratio | ***** | ***** | ***** | ***** | ***** |
| ICR | ***** | ***** | ***** | ***** | ***** |
Consolidated Statements
Income Statement, Balance Sheet, Cash Flow & Ratios available in the full report.
Charges & Borrowings Socrus Bio Sciences Limited
Socrus Bio Sciences Limited does not have any charges (loans) registered with the Registrar of Companies.
Employees and EPFO Compliance at Socrus Bio Sciences Limited
View historical data on people associated with Socrus Bio Sciences Limited, including employment history and EPFO contributions.
Employee Count & EPFO Data of Socrus Bio Sciences Limited
Access employee headcount trends, monthly PF payment records, EPFO establishment details, and compliance data.
GST Compliance of Socrus Bio Sciences Limited
GSTIN & GST Filing Data of Socrus Bio Sciences Limited
Access GSTIN registrations, state-wise filing compliance, HSN/SAC codes, and detailed goods & services data.
Credit Ratings, Litigation & Regulatory Alerts for Socrus Bio Sciences Limited
Credit Ratings, Legal Cases & Regulatory Alerts of Socrus Bio Sciences Limited
Access complete credit rating history, litigation records, regulatory alerts, and compliance data.
MSME Payment Delays by Socrus Bio Sciences Limited
MSME Payment Delays by Socrus Bio Sciences Limited
Track payments outstanding to micro and small enterprise vendors, as disclosed in half-yearly MSME-1 returns filed with the MCA.
Subsidiaries & Group Companies of Socrus Bio Sciences Limited
Subsidiaries & Group Companies of Socrus Bio Sciences Limited
See the full corporate group - holding company, subsidiaries, associates and joint ventures of Socrus Bio Sciences Limited with ownership details.
MCA Filings & Documents of Socrus Bio Sciences Limited
MCA Filings & Documents of Socrus Bio Sciences Limited
Download official documents filed with the Ministry of Corporate Affairs - from incorporation papers to the latest annual filings.
Recent Activity on Socrus Bio Sciences Limited
Frequently Asked Questions about Socrus Bio Sciences Limited
Socrus Bio Sciences Limited is an active public limited company in the information technology sector based in Mumbai, Maharashtra, India. It was incorporated on 25 October 1989 (37+ years old) and is registered under CIN U99999MH1989PLC054030.
The current directors of Socrus Bio Sciences Limited are:
The primary industry of Socrus Bio Sciences Limited is information technology. The company specifically operates in software development and support services. The company is currently active in this sector.
Socrus Bio Sciences Limited can be reached at the registered office: 30 16 – A Pmgp Colony Mahakali Cave Road Andheri E, Mumbai, Maharashtra, India – 400093, or through the website socrus.com.
The authorised capital is ₹32.01 Cr, and the paid-up capital is ₹32 Cr.
The company has its registered office at 30 16 – A Pmgp Colony Mahakali Cave Road Andheri E, Mumbai, Maharashtra, India – 400093.